|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-5-26
|
|
pubmed:abstractText |
To compare the efficacy and tolerability of imidafenacin, a novel antimuscarinic agent, with propiverine and a placebo in Japanese patients with overactive bladder (OAB).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1442-2042
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
499-506
|
|
pubmed:meshHeading |
pubmed-meshheading:19389083-Adult,
pubmed-meshheading:19389083-Aged,
pubmed-meshheading:19389083-Aged, 80 and over,
pubmed-meshheading:19389083-Asian Continental Ancestry Group,
pubmed-meshheading:19389083-Benzilates,
pubmed-meshheading:19389083-Cholinergic Antagonists,
pubmed-meshheading:19389083-Double-Blind Method,
pubmed-meshheading:19389083-Female,
pubmed-meshheading:19389083-Humans,
pubmed-meshheading:19389083-Imidazoles,
pubmed-meshheading:19389083-Male,
pubmed-meshheading:19389083-Middle Aged,
pubmed-meshheading:19389083-Muscarinic Antagonists,
pubmed-meshheading:19389083-Placebos,
pubmed-meshheading:19389083-Treatment Outcome,
pubmed-meshheading:19389083-Urinary Bladder, Overactive,
pubmed-meshheading:19389083-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder.
|
|
pubmed:affiliation |
Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. homma-uro@umin.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
